期刊文献+

血小板、D-二聚体在感染性休克早期集束化治疗中的临床应用 被引量:2

Clinical study of platelet and D-dimer in the early bundle treatment of septic shock
下载PDF
导出
摘要 目的探讨血小板、D-二聚体在感染性休克早期集束化治疗中的临床应用价值。方法随机选取成人综合ICU感染性休克患者60例,均予以早期集束化治疗。于集束化治疗前、治疗后6h,入ICU1、2、3、4、5d,分别检测血小板计数、D-二聚体浓度,并分别记录各时间点急性生理学和慢性健康状况评分系统II(APACHEII)评分。根据患者28d转归分为存活组与死亡组,比较两组不同时间点相关指标,并对本组内各时间点相关指标与集束化治疗前进行比较。分别将两组内血小板计数、D-二聚体浓度与APACHEII评分进行相关分析。结果存活组APACHEII评分、D-二聚体随着病情好转下降,死亡组则呈升高趋势;存活组血小板计数随着病情好转逐渐升高,而死亡组则逐渐下降。经Pearson相关分析,APACHEII评分与血小板计数呈负性相关(t=-0.862,P〈0.01),与D-二聚体浓度呈正相关(,=0.445,P〈0.01)。结论血小板计数、D-二聚体浓度可作为感染性休克治疗效果及预后的评价指标,与APACHEII评分结合,能更准确地评估感染性休克病情的严重程度及预后。 Objective To study the clinical application of platelet and D-dimer in the early bundle treatment of septic shock. Methods 60 cases of septic shock in adult comprehensive ICU who accepted early bundle treatment were selected randomly. Platelet count and D-dimer concentration were respectively tested before bundle treatment, 6 hours after bundle treatment, 1, 2, 3, 4, 5 d after entering ICU. APACHE II score was recorded respectively at different time points. Patients were divided into survival group and death group according to the outcome within 28 days. The related indexes at different time points between two groups were compared, and the indexes within the group were compared with the indexes before bundle treatment. Correlation analysis was respectively studied between platelet count, D-dimer concentration and APACHE II score within two groups. Results APACHE II score and D-dimer concentration declined with the improvement of the disease in survival group, and it was opposite in death group. Platelet count gradually went up with the improvement of the disease in survival group, and it was opposite in death group. Pearson correlation analysis showed that APACHE II score was negatively correlated with platelet count (r=-0.862, P 〈 0.01), and positively correlated with D-dimer concentration (r=0.445). Conclusion Platelet count and D-dimer concentration can be indexes to evaluate therapeutic effect and prognosis of septic shock, which can more accurately evaluate the severity and prognosis of septic shock when combined with APACHE II score.
出处 《国际医药卫生导报》 2016年第11期1545-1547,共3页 International Medicine and Health Guidance News
关键词 血小板计数 D-二聚体 急性生理学和慢性健康状况评分系统II(APACHE II) 感染性休克 Platelet count D-dimer APACHE II score Septic shock
  • 相关文献

参考文献11

  • 1Levi M.The coagulant response in sepsis and inflammation[J].Hamostaseologie,2010,30(1):10-12,14-16.
  • 2Thiolliere F,Serre-Sapin AF,Reignier J,et al.Epidemiology and outcome of thrombocytopenic patients in the intensive care unit:results of a prospective multicenter study[J].Intensive Care Med,2013,39(8):1460-1468.
  • 3Thiele T,Selleng K,Selleng S,et al.Thrombocytopenia in the intensive care unit-diagnostic approach and management[J].Semin Hematol,2013,50(3):239-250.
  • 4Annane D,Bellissant E,Cavaillon JM.Septic shock[J],Lancet,2005,365(9453):63-78.
  • 5Boechat Tde O,Silveira MF,Faviere W,et al.Thrombocitopenia in aepsis:an important prognosis factor[J].Rev Bras Ter Intensiva,2012,24(1):35-42.
  • 6Thiele T,Selleng K,Selleng S,et al.Thrombocy-topenia in the intensive care unit-diagnostic approach and management[J].Semin Hematol,2013,50(3):239-250.
  • 7Kraemer BF,Campbell RA,Schwertz H,et al.Bacteria difkrentially induce degradation of Bcl-xL,a suvival protein,by human platelets[J].Blood,2012,120(25):5014-5020.
  • 8Yin H,Stojanovic-Terpo A,Xu W,et al.Role for platelet glycoprotein Ib-IX and efkcts of its inhibition in endotoxemia-induced thrombosis,thrombocytopenia,and mortality[J].Arterioscler Thromb Vasc Biolf 2013,33(11):2529-2537.
  • 9Rodeio JR,De la Rosa G,Valencia ML.D-dimer is a significant prognostic factor in patients with suspected infection and sepsis[J].Am J Emerg Med,2012,30(9):1991-1999.
  • 10占志刚,李春盛.D-二聚体对急诊脓毒症患者预后价值的前瞻性研究[J].中国危重病急救医学,2012,24(3):135-139. 被引量:40

二级参考文献35

  • 1刘晓蓉,任新生,徐杰,李家瑞,王静.血必净注射液治疗脓毒症凝血功能障碍的疗效观察[J].中国中西医结合急救杂志,2006,13(4):252-252. 被引量:32
  • 2王秀香,杨敬平,孙德俊.COPD急性加重的诱因及病原[J].临床肺科杂志,2006,11(2):176-177. 被引量:26
  • 3苏艳丽,王红,张淑文.脓毒症的凝血功能紊乱与抗凝治疗研究进展[J].中国危重病急救医学,2006,18(11):698-701. 被引量:45
  • 4慢性阻塞性肺疾病诊治指南(2007年修订版)[J].中华结核和呼吸杂志,2007,30(1):8-17. 被引量:8230
  • 5Kline JA, Runyon MS, Webb WB,et al. Prospective study of the diagnostic accuracy of the simplify D-dimer assay for pulmonary embolism in emergency department patients. Chest,2006,129: 1417-1423.
  • 6Wells PS, Anderson DR, Rodger M, et al. Evaluation of D-dimer in the diagnosis of suspected deep-vein thrombosis. N Engl J Med,2003,349 : 1227-1235.
  • 7Cushman M, Folsom AR, Wang L, et al. Fibrin fragment D-dimer and the risk of future venous thrombosis. Blood, 2003,101 : 1243-1248.
  • 8Palareti G, Cosmi B, Legnani C,et al. D-dimer testing to deter- mine the duration of anticoagulation therapy. N Engl J Med, 2006,355 : 1780-1789.
  • 9Danesh J, Whincup P, Walker M, et al. Fibrin D-dimer and coronary heart disease: prospective study and meta-analysis. Circulatian, 2001,103 : 2323-2327.
  • 10Buccheri G,Torchio P,Ferrigno D. Plasma levels of D-dimer in lung carcinoma:clinical and prognostic significance. Cancer, 2003,97 : 3044-3052.

共引文献45

同被引文献18

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部